Douglas C. Lane & Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q4 | $45.7M | Sell |
592,289
-11,528
| -2% | -$889K | 1.24% | 29 |
|
2015
Q3 | $49.7M | Sell |
603,817
-3,323
| -0.5% | -$274K | 1.41% | 21 |
|
2015
Q2 | $53.5M | Sell |
607,140
-4,030
| -0.7% | -$355K | 1.44% | 19 |
|
2015
Q1 | $54M | Sell |
611,170
-8,323
| -1% | -$735K | 1.42% | 19 |
|
2014
Q4 | $51.4M | Sell |
619,493
-900
| -0.1% | -$74.7K | 1.39% | 19 |
|
2014
Q3 | $52.3M | Buy |
620,393
+1,635
| +0.3% | +$138K | 1.56% | 17 |
|
2014
Q2 | $50.2M | Sell |
618,758
-3,425
| -0.6% | -$278K | 1.52% | 16 |
|
2014
Q1 | $47.4M | Buy |
622,183
+10,483
| +2% | +$799K | 1.52% | 17 |
|
2013
Q4 | $44.1M | Buy |
611,700
+646
| +0.1% | +$46.5K | 1.46% | 19 |
|
2013
Q3 | $42M | Buy |
611,054
+2,595
| +0.4% | +$178K | 1.53% | 14 |
|
2013
Q2 | $38.6M | Buy |
+608,459
| New | +$38.6M | 1.5% | 14 |
|